New Post

Pfizer To Acquire Cancer Drug Producer Medivation

Monday, August 22, 2016 – Pfizer Inc. (NYSE:PFE) and Medivation, Inc. (NASDAQ:MDVN) today announced that they have entered into a definitive merger agreement under which Pfizer will acquire Medivation, a biopharmaceutical company focused on developing and commercializing small molecules for oncology, for $81.50 a share in cash for a total enterprise value of approximately $14 […]

Read More

Teva Announces Acquisition of Allergan’s Anda Inc. For $500 million

JERUSALEM- Aug. 3, 2016– Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced that it has entered into a definitive agreement to purchase Allergan’s Anda Inc., the 4th largest distributor of generic pharmaceuticals in the U.S. for $500 million. “Anda is a natural fit into our business in general and our extensive supply chain […]

Read More

GSK and Verily To Establish Galvani Bioelectronics – A New Company Dedicated To The Development Of Bioelectronic Medicines

GSK (LSE/NYSE: GSK) today announced an agreement with Verily Life Sciences LLC (formerly Google Life Sciences), an Alphabet company, to form Galvani Bioelectronics to enable the research, development and commercialisation of bioelectronic medicines. GSK will hold a 55% equity interest in the new jointly owned company and Verily will hold 45%. Galvani Bioelectronics will be […]

Read More

New Zika Response Strategy To Focus On Preventing, Managing Medical Complications

The United Nations health agency today issued a revised strategic response plan for the next one and a half years to combat the transmission of the Zika virus, which has now spread to 60 countries. The Zika Strategic Response Plan from July 2016 to December 2017 would place a greater focus on preventing and managing […]

Read More

Pfizer Announces Termination Of Proposed Combination With Allergan

NEW YORK, N.Y., April 6 – Pfizer Inc. (NYSE: PFE) today announced that the merger agreement between Pfizer and Allergan plc (NYSE: AGN) has been terminated by mutual agreement of the companies. The decision was driven by the actions announced by the U.S. Department of Treasury on April 4, 2016, which the companies concluded qualified […]

Read More

FDA Announces Enhanced Warnings for Immediate-release Opioid Pain Medications Related to Risks of Misuse, Abuse, Addiction, Overdose and Death

In a continuing effort to educate prescribers and patients about the potential risks related to opioid use, the U.S. Food and Drug Administration today announced required class-wide safety labeling changes for immediate-release (IR) opioid pain medications. Among the changes, the FDA is requiring a new boxed warning about the serious risks of misuse, abuse, addiction, […]

Read More

McKesson to Acquire Rexall Health from Katz Group, Strengthens its Position in Canada’s Pharmaceutical Supply Chain

SAN FRANCISCO and TORONTO – McKesson Corporation (NYSE: MCK), a leading international healthcare services and information technology company, and Katz Group, one of Canada’s largest privately-owned enterprises, today announced a definitive agreement to acquire Rexall Health from Katz Group for $3 billion CAD ($2.2 billion USD*, or approximately $1.9 billion USD* net of the present […]

Read More

Federal Antitrust Agencies Submit Joint Statement Encouraging Massachusetts to Consider Expanding Treatment Options for Glaucoma Patients

In response to a request by Massachusetts State Representative Bradley H. Jones, the Federal Trade Commission and the Department of Justice’s Antitrust Division have submitted a statement encouraging the Massachusetts legislature to consider expanding the services that optometrists can provide to glaucoma patients. Specifically, Representative Jones asked the agencies for views on the possible competitive […]

Read More

WHO To Convene an International Health Regulations Emergency Committee on Zika Virus

WHO Director-General, Margaret Chan, will convene an International Health Regulations Emergency Committee on Zika virus and observed increase in neurological disorders and neonatal malformations. The Committee will meet on Monday 1 February in Geneva to ascertain whether the outbreak constitutes a Public Health Emergency of International Concern. Decisions concerning the Committee’s membership and advice will […]

Read More

HHS and USDA Release New Dietary Guidelines to Encourage Healthy Eating Patterns to Prevent Chronic Diseases

WASHINGTON, – Secretary of Health and Human Services Sylvia M. Burwell and Secretary of Agriculture Tom Vilsack today released updated nutritional guidelines that encourage Americans to adopt a series of science-based recommendations to improve how they eat to reduce obesity and prevent chronic diseases like Type 2 diabetes, hypertension, and heart disease. The 2015-2020 Dietary […]

Read More